Refreshing results…
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation
Download from doi.orgMicroRNAs in kidney injury and disease
UploadShould we consider calcimimetics as a therapeutic option for nephrotic syndrome?
UploadParietal epithelial cell dysfunction in crescentic glomerulonephritis
UploadImpaired type I interferon activity and inflammatory responses in severe COVID-19 patients
UploadMissing publications? Search for publications with a matching author name.